MYLAN PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS INDUSTRIES LTD. et al
Case Number:
2:21-cv-13087
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 03, 2025
Teva Should Face Key Copaxone Antitrust Claims, Court Told
Mylan and pharmaceutical wholesalers should be allowed to proceed with some, but not all, parallel claims accusing Teva of using regulatory deception, false advertising, improper rebates and more to delay generic competition to its Copaxone multiple sclerosis treatment, a special master has recommended in New Jersey federal court.
-
November 22, 2021
Teva Says Mylan Is Just Unhappy About MS Drug Competition
Teva Pharmaceuticals has urged a New Jersey federal court to toss a suit from Mylan accusing the generic-drug giant of an illegal scheme to stifle competition to its multiple sclerosis treatment, arguing that Mylan is just misplacing blame for its own disappointment.